Nyxoah SA NYXH
Annual
Quarterly
No annual revenue total was found in NYXOAH SA's SEC filings.
Nyxoah SA (NYXH) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
43.03M
+15.0% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NYXH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Belgium
- Headquarters
- Mont-Saint-Guibert
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1857190
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 20, 2026 | Oct 20, 2026 |
| 6-K | Current report (foreign issuer) | Sep 29, 2026 | Sep 29, 2026 |
| 6-K | Current report (foreign issuer) | Sep 22, 2026 | Sep 22, 2026 |
| 6-K | Current report (foreign issuer) | Aug 5, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 9, 2026 | Jul 9, 2026 |
| 6-K | Current report (foreign issuer) | Jun 23, 2026 | Jun 23, 2026 |
Source: SEC EDGAR filings. This is company-reported data, not investment advice.